ATI · ATI Inc. · Stock research

Current Thesis

The give-back that started the week of 2026-08-17 stopped on the fifth session. Closes: $228.48 on 2026-08-14, $215.99 on 2026-08-19 (-4.6%), $209.22 on 2026-08-20 (-3.13%), $207.01 on 2026-08-21 (-1.06%), then $209.81 on 2026-08-24 (+1.35%). That leaves price 9.5% under the $231.78 52-week high in the adjusted daily series, RSI(14) at 57.4 against 59.9 three sessions earlier, and a three-month price change of +24.3%. One green session after four red ones is a pause in the decay, not a completed base.

Nothing company-published has landed since the 2026-08-06 Q2 8-K. The scarcity leg being bought is unchanged and unrevised: melt and billet capacity rationing an order book that end demand has already filled. Aerospace and defense was 68% of Q2 sales, backlog printed a record $4.4B (+18% YoY) against the $4.1B record cited at the 2026-04-30 Q1 report, and FY26 adjusted EBITDA guidance moved to $1.135–$1.185B from $1.010–$1.060B on 2026-08-06.

The narrative is maturing, unchanged from the prior refresh, and the flow markers are dated. Every post-print target action clustered inside six sessions — BTIG $270 and Susquehanna $265 (2026-08-07), Wells Fargo $275 from $175 and Deutsche Bank $262 from $231 (2026-08-10), KeyBanc $258 from $211 (2026-08-12) — and nothing has been dated since. Nine-analyst consensus of $248.44 has not changed since 2026-08-16, so published implied upside widened mechanically from 8.74% at the 2026-08-14 close to 18.41% at $209.81 without a single estimate moving. Benzinga's 2026-08-10 ten-year retrospective-returns piece is the kind of coverage that follows a move. The next company-published number is roughly nine weeks out.

Bullish and bearish views on ATI Inc.

The model's bull view on ATI Inc. (ATI), in brief: Q2 2026 (2026-08-06): sales $1,261.1M (+11% YoY) against roughly $1.218B consensus; adjusted EPS $1.23 versus $1.04 estimated; adjusted EBITDA $284.4M at 22.6% of sales, +440bps YoY. The bear view: Valuation carries the scarcity premium: forward P/E of 38.22 and a market capitalisation of $28.57B at the 2026-08-24 close, per stockanalysis.com. Both cases follow in full.

Bull Case

• Q2 2026 (2026-08-06): sales $1,261.1M (+11% YoY) against roughly $1.218B consensus; adjusted EPS $1.23 versus $1.04 estimated; adjusted EBITDA $284.4M at 22.6% of sales, +440bps YoY. Q1 2026 printed $231.7M at 20.1%, so the margin step is one quarter old and has not yet been re-tested.
• All three FY26 metrics were raised together on 2026-08-06: adjusted EBITDA $1.135–$1.185B, adjusted EPS $4.90–$5.18 from $4.20–$4.48, adjusted free cash flow $550–$600M from $465–$525M. Q3 was guided to $305–$315M EBITDA and $1.31–$1.37 EPS, above the Q2 run-rate.
• Segment detail at Q2: AA&S sales $624.0M (+17% YoY) with A&D at 44% of segment sales and +34% YoY; HPMC sales $637.1M (+5% YoY), segment EBITDA $153.5M at a 24.1% margin, A&D 93% of segment sales.
• The five-session drawdown widened the gap to a static consensus rather than closing it: $248.44 across nine analysts, last changed 2026-08-16, implying 18.41% at the 2026-08-24 close of $209.81.
• Contracted volume that sits outside the commercial-air rate cycle, including the roughly $1B five-year BWX Technologies naval agreement, supports the defense half of the mix independent of Boeing and Airbus monthly deliveries.

Bear Case

• Valuation carries the scarcity premium: forward P/E of 38.22 and a market capitalisation of $28.57B at the 2026-08-24 close, per stockanalysis.com. A Q3 backlog that prints below the record $4.4B removes the main support for that multiple.
• Officer supply printed within two dollars of the high. A Form 4 covering 2026-08-17 discloses Chair, President and CEO Kimberly Fields selling 24,845 shares in five blocks at $228.32, $229.56, $230.66, $231.72 and $232.43 — roughly $5.74M — The filings cite the Rule 10b5-1 plan dated 2026-02-05, so timing is pre-scheduled; the price band is still where the supply cleared.
• Company buying happened far lower. Repurchase behaviour at $159.53 says nothing about corporate demand at $210.
• Rate risk is live in the OEM data: Boeing delivered 39 737 MAX in July against the 42/month target, and Airbus had delivered 418 aircraft through July against the roughly 870-aircraft FY26 guide reaffirmed 2026-07-29.
• Q2 AA&S segment EBITDA of $147.6M included a $9.9M gain on a facility sale, so the 23.7% segment margin overstates the run-rate. Q1 2026 also set the pattern of an EPS beat carried by price and mix while revenue came in light.

Setup & Price Structure

• Reference levels, all closes in the adjusted series: $231.78 (52-week high), $228.48 (2026-08-14), $209.81 (2026-08-24), $200.15 (2026-08-04, the last close before the Q2 print), $183.30 (the June breakout shelf reclaimed on the way up).
• The decay pattern is the structure: -4.6%, -3.13%, -1.06%, +1.35%. Selling pressure shrank each session, but two closes above $209 do not constitute a base, and the $228.32–$232.43 insider block prices sit directly overhead as a reference band for supply.
• RSI(14) at 57.4 is mid-range — it neither confirms exhaustion nor flags an overbought condition, and it has cooled from the roughly 66 reading noted during the June digestion phase.
• The whole post-print re-rating lives in the $200.15 → $231.78 band. Losing $200.15 on a closing figure means the 2026-08-06 guidance raise has been fully round-tripped by the tape.
• Crowding observables, stated as observed: consensus static for six sessions at $248.44; no dated target action since 2026-08-12; retrospective-returns coverage on 2026-08-10; insider selling into the high under a pre-scheduled plan; no earnings date inside 30 days. There is no equity issuance into strength — the June financing was debt, and roughly leverage-neutral.

Catalyst Calendar (next 30 days)

• ~2026-09-03 (est.) — Forecast International monthly commercial-aircraft production tracking for August 2026. Leading indicator with known error: its 2026-08-03 estimate ran two aircraft light on Boeing's July total and two light on the MAX count.
• ~2026-09-08 (est.) — Airbus August 2026 orders and deliveries. Measured against 418 aircraft through July and the roughly 870-aircraft FY26 guide reaffirmed 2026-07-29, this is the rate input behind titanium plate and sheet volumes.
• ~2026-09-09 (est.) — Boeing August 2026 orders and deliveries. A second consecutive month with 737 MAX deliveries below the 42/month target, after July's 39, would frame the shortfall as a rate problem rather than a timing effect.
• ~2026-10-29 (est.) — Q3 2026 results. Outside the 30-day window, and the first test of the $305–$315M adjusted EBITDA guide. Nothing company-published resolves before it.

Elapsed catalysts

• No ATI-hosted event has surfaced in the news flow for September as of 2026-08-25. The company's last conference appearance in the record is the Bernstein Strategic Decisions Conference on 2026-05-28. (passed 1d ago)

What Would Change Our Mind

The structural break is the loss of the post-print range. The entire re-rating from the 2026-08-06 guidance raise sits above the 2026-08-04 pre-print close of $200.15; a daily close below $200 means the tape has taken all of it back and the raise no longer supports price. Below that, a weekly close below $183.30 converts the June breakout into a failure and removes the last reclaimed shelf.

On the fundamentals, a Q3 report (~2026-10-29) with backlog below the record $4.4B, or HPMC lead times described on the call as shortening from the near-two-year figure cited in April, would break the scarcity premise directly rather than through price. A third-consecutive Boeing month under 42 MAX per month, starting with the ~2026-09-09 report, would do the same to the volume leg.

Two conditions would flip the life-cycle read to saturated: a new cluster of retail-facing "how much would $100 be worth" coverage without an accompanying estimate change, and target actions that stop moving while price grinds higher into them. Conversely, a fresh dated target revision after 2026-08-12 with an accompanying estimate change would show the sell-side is still adding to the leg rather than marking it.

Correlation Notes

• The name trades with its specialty-metals peers through catalyst windows. Reference closes on 2026-08-04, the session before the Q2 print: ATI $200.15, Carpenter Technology $570.13, Howmet $288.20. A peer-specific disappointment that drags all three lower with no ATI headline attached is sector beta, not a company event.
• Carpenter Technology's fiscal year ends 30 June, so its FY27 guidance spans ATI's Q3 and Q4 calendar quarters. Comparing the two guides without adjusting the period produces a false read.
• Boeing and Airbus monthly delivery data is the highest-frequency input into the AA&S volume line; the aerospace and defense mix at 68% of Q2 sales means OEM rate news moves the name faster than any metals index.
• The defense half of the book — the BWXT naval agreement, plus A&D at 93% of HPMC segment sales — is contracted volume that does not respond to commercial narrow-body rate changes, which is why the two halves of the story can diverge inside a single quarter.